DocCheck AG (XTER:AJ91) Inventories, Raw Materials & Components: €0.11 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:AJ91 DocCheck AG XTER:AJ91
71 GF Score
Price €11.80
GF Value €9.52
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is DocCheck AG Inventories, Raw Materials & Components?

DocCheck AG XTER:AJ91 71 Inventories, Raw Materials & Components is €0.11 Mil as of Dec. 2025. GuruFocus rates XTER:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.52 (Modestly Overvalued). The stock has 3 warning signs investors should review.

DocCheck AG's inventories, raw materials & components for the quarter that ended in Dec. 2025 was €0.11 Mil.

DocCheck AG's quarterly raw materials declined from Dec. 2024 (€0.06 Mil) to Jun. 2025 (€0.00 Mil) but then increased from Jun. 2025 (€0.00 Mil) to Dec. 2025 (€0.11 Mil).

DocCheck AG's annual raw materials declined from Dec. 2023 (€0.10 Mil) to Dec. 2024 (€0.06 Mil) but then increased from Dec. 2024 (€0.06 Mil) to Dec. 2025 (€0.11 Mil).

DocCheck AG Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for DocCheck AG's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DocCheck AG Inventories, Raw Materials & Components Chart

DocCheck AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.09 0.10 0.06 0.11

DocCheck AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.00 0.06 0.00 0.11
XTER:AJ91
71GF Score
DocCheck AG XTER:AJ91
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DocCheck AG Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €0.11 Mil mean?
DocCheck AG (XTER:AJ91) has a Inventories, Raw Materials & Components of €0.11 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on DocCheck AG and its competitors.
Is DocCheck AG's Inventories, Raw Materials & Components too high?
DocCheck AG's current Inventories, Raw Materials & Components is €0.11 Mil. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's Inventories, Raw Materials & Components compare to VEEV and BTSG?
DocCheck AG's Inventories, Raw Materials & Components of €0.11 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Healthcare Providers & Services company?
A good Inventories, Raw Materials & Components depends on the Healthcare Providers & Services industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on DocCheck AG and its competitors. DocCheck AG's current Inventories, Raw Materials & Components is €0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (XTER:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.52, compared to a current price of €11.80 — trading 23.9% above its estimated fair value. The current Inventories, Raw Materials & Components is €0.11 Mil. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For DocCheck AG (XTER:AJ91), the current Inventories, Raw Materials & Components is €0.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DocCheck AG (XTER:AJ91) Overvalued in 2026?

Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued. The current stock price of €11.80 is trading 23.9% above its estimated GF Value™ of €9.52. GuruFocus considers DocCheck AG to be Modestly Overvalued.

Key valuation signals for XTER:AJ91:

  • Inventories, Raw Materials & Components: €0.11 Mil
  • GF Value™: €9.52 vs. price of €11.80 (23.9% above fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the XTER:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DocCheck AG Business Description

Address Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score

Get the complete analysis for XTER:AJ91

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.80
Price
€9.52
GF Value